Plasma Concentrations of Carbamazepine and Carbamazepine 10,11-Epoxide During Pregnancy and After Delivery
- 1 January 1985
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 10 (3) , 279-284
- https://doi.org/10.2165/00003088-198510030-00007
Abstract
Plasma concentrations of carbamazepine were monitored in 9 pregnant epileptic patients treated with the drug alone at constant doses during pregnancy and for at least 3 months after delivery. In addition, plasma concentrations of the metabolite, carbamazepine 10,11-epoxide were measured in 6 of the 9 patients. Plasma carbamazepine concentrations were fairly stable during pregnancy, and carbamazepine relative plasma clearances were significantly higher in weeks 4 to 24 than in weeks 25 to 52. After the end of the second trimester, there were no variations in plasma carbamazepine 10,11-epoxide concentrations and carbamazepine 10.11-epoxide: carbamazepine ratios. Both parameters were significantly higher in weeks 4 to 24 than in weeks 25 to 32 of pregnancy.This publication has 10 references indexed in Scilit:
- Plasma Levels and Clinical Effects of Antiepileptic Drugs in Pregnant Epileptic Patients and Their NewbornsObstetrical & Gynecological Survey, 1980
- Action of Pregnancy and Various Progesterones on Hepatic Microsomal ActivitiesDrug Metabolism Reviews, 1979
- Antiepileptic DrugsClinical Pharmacokinetics, 1979
- Status epilepticus in pregnancyNeurology, 1978
- Plasma anticonvulsant concentrations during pregnancyNeurology, 1977
- Drug Kinetics in PregnancyClinical Pharmacokinetics, 1977
- Plasma Drug Level Monitoring in PregnancyClinical Pharmacokinetics, 1977
- PHENYTOIN and PHENOBARBITONE PLASMA CLEARANCE DURING PREGNANCYActa Neurologica Scandinavica, 1976
- CARBAMAZEPINE PHARMACOKINETICS IN YOUNG, ADULT AND PREGNANT RATS - RELATION TO PHARMACOLOGICAL EFFECTS1976
- Effects of Age, Sex, Obesity, and Pregnancy on Plasma Diphenylhydantoin LevelsEpilepsia, 1974